Table 1 Antibacterial activity of synthesized compounds (zone of inhibition in diameter in mm)
Tested microorganisms comp. no | Gram positive bacteria inhibition zone diameter in mm and (%) value | Gram negative bacteria inhibition zone diameter in mm and (%) value | ||
|---|---|---|---|---|
Streptococcus pneumoniae | Bacillus subtilis | Pseudomonas aeruginosa | Escherichia coli | |
St. | Ampicillin | Gentamicin | ||
23.8 ± 0.2 | 32.4 ± 0.3 | 17.3 ± 0.1 | 19.9 ± 0.3 | |
2 | 16.9 ± 0.58 (71.0%) | 18.2 ± 0.44 (56.2%) | 10.7 ± 0.34 (61.8%) | 11.9 ± 0.63 (59.8%) |
3 | 12.9 ± 0.63 (54.2%) | 13.2 ± 0.58 (40.7%) | 11.8 ± 0.36 (67.2%) | 10.8 ± 0.44 (54.3%) |
4 | 16.7 ± 0.54 (70.2%) | 17.4 ± 0.63 (53.7%) | 14.1 ± 0.52 (81.5%) | 13.2 ± 0.47 (66.3%) |
5 | 19.3 ± 0.67 (81.1%) | 14.6 ± 0.57 (45.1%) | 13.6 ± 0.42 (78.6%) | 14.5 ± 0.54 (72.9%) |
6 | 16.5 ± 0.78 (69.3%) | 17.7 ± 0.63 (54.6%) | 14.2 ± 0.56 (82.1%) | 15.7 ± 0.52 (78.9%) |
7a | 18.2 ± 0.44 (76.5%) | 20.3 ± 0.35 (62.7%) | 17.1 ± 0.34 (98.8%) | 20.3 ± 0.29 (102%) |
7b | 23.8 ± 0.2 (100%) | 32.4 ± 0.3 (100%) | 17.3 ± 0.1 (100%) | 19.9 ± 0.3 (100%) |
8 | 23.8 ± 0.2 (100%) | 32.4 ± 0.3 (100%) | 17.3 ± 0.1 (100%) | 19.9 ± 0.3 (100%) |
9 | 16.4 ± 0.52 (68.9%) | 13.9 ± 0.39 (42.9%) | 13.2 ± 0.38 (76.3%) | 12.8 ± 0.38 (64.3%) |
10 | 12.8 ± 0.34 (53.8%) | 15.4 ± 0.53 (47.5%) | 11.9 ± 0.32 (67.8%) | 11.6 ± 0.35 (58.3%) |
11a | 14.6 ± 0.58 (61.3%) | 14.3 ± 0.58 (44.1%) | 10.2 ± 0.32 (59.0%) | 9.4 ± 0.44 (47.2%) |